Clinical Trial Update: Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of liposomal vincristine in patients with malignant melanoma and hepatic dysfunction has completed; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Liposomal vincristine (vincristine liposome)

Snippet

Sponsor: Acrotech Biopharma Inc. | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2012-01-05